Pfizer Limited announced that Mr. Milind Patil has resigned as a Director on the Board with effect from close of business on November 13, 2023, consequent to the expiry of his 5 year term as Executive Director - Finance effective the said date and his upcoming retirement from the services of the Company effective November 30, 2023. Pursuant to the above, Mr. Patil shall cease to be a Member of the Corporate Social Responsibility Committee, Risk Management Committee and Board Administrative & Share Transfer Committee of the Board effective close of business on November 13, 2023. It may be noted that Mr. Patil shall continue to serve as the Chief Financial Officer of the Company until his retirement on November 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,194 INR | +1.22% | +1.54% | -1.76% |
Apr. 02 | Pfizer Limited Appoints Amit Agarwal as Chief Financial Officer | CI |
Apr. 02 | Pfizer Limited Appoints Amit Agarwal as Whole-Time Director, Designated as Executive Director Finance | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.76% | 2.3B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- PFIZER Stock
- News Pfizer Limited
- Pfizer Limited Announces Resignation of Mr. Milind Patil as Director with Effect from Close of Business on November 13, 2023